Applying precision medicine to the active surveillance of prostate cancer

E-ISSN： 1097-0142|121|19|3403-3411

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.19, 2015-10, pp. : 3403-3411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Point: Active Surveillance for Favorable Risk Prostate Cancer

By Klotz Laurence

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 7, 2007-08 ,pp. : 693-698

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2465-2473

Blackwell Publishing

Access to resources Recommend Favorite

Personalized Precision Medicine in Cancer: A Theranostic Approach

Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. : 166-170

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 10, 2016-08 ,pp. : 856-865

Bentham Science Publishers

Access to resources Recommend Favorite

Active-Targeted Nanotherapy Strategies for Prostate Cancer

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 954-965

Bentham Science Publishers

Access to resources Recommend Favorite